Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in wockhardt

UK Extends COVID-19 Vaccine Supply Deal With India's Wockhardt

The agreement is now expanded to August 2022, and Wockhardt will continue to make vaccines at its unit in Wrexham in Wales

Read More

Wockhardt announces Covid-19 vaccine partnership with UK government

Wockhardt announces Covid-19 vaccine partnership with UK government

Read More

Wockhardt To Supply Millions Of Doses Of COVID-19 Vaccines To UK

The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of an agreement with the UK government

Read More

Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter

Dr Reddy's net profit falls 13 pc to Rs 579 cr in June quarter

Read More

Wockhardt's Profitability For Q4 Improves To Rs 48 Crore

The earnings before interest, taxes, depreciation and amortisation (EBITDA) for the quarter showed an improvement from Rs 34 crore to Rs 37 crore.

Read More

Wockhardt Back In Black After 3 Years, Stock Jumps 15% Intraday

The company's revenue came in at Rs 869 crore versus Rs 1,046 crore in the same period.

Read More

Pharma: FDA Blues

Indian pharma companies have had to pay a heavy cost for non-compliance with US FDA regulations and post-ban remedial measures using pricey foreign consultants unfamiliar with the country. Now, help is available locally and at a much cheaper cost

Read More

Skilling Health Care Managers

Until recently, doctors had to double up as administrators at hospitals. Now, with some colleges training managers specifically for the healthcare industry, the doctors can go back to doing what they do best

Read More

Cipla, Wockhardt In Talks For A Broader Business Alliance

The alliance, which may even lead to a merger or equity collaboration between the two drugmakers, is expected to be announced soon

Read More

Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016

The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind

Read More

Drugs Ban | Partial Relief From High Court For Wockhardt, Glaxo And Griffon

The drugs which were subject matter of today's plea are Aceproxyvon, Viscodyne and Viscodyne-D of Wockhardt, Crocin Cold and Flu Max of Glaxo and Grilinctus syrup of Griffon.

Read More

US Regulator Finds Wockhardt Hid Data On Failed Tests

Wockhardt is the latest of several major players in the $15 billion Indian drugs industry to be hit by US regulatory action over the past few months

Read More

FDA Observations Not Critical, Says Wockhardt

The company says none of the nine observations made by the FDA are critical and these issues can be resolved in next 2 to 3 months

Read More

Inviting Higher Risks By Challenging FDA

The industry captains allege that the FDA does not follow systems while conducting audits and follow-up actions and it doesn’t respond on time to company replies

Read More